Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Research Abstract |
Small interfering RNA(siRNA) is a non-coding RNA with considerable potential as a new therapeutic drug for intractable diseases. siRNAs can be rationally designed and synthesized if the sequences of the disease-causing genes are known. In this study, we found that incorporation of naphthalene biaryl unit at the 5' and 3' ends of sense and antisense strands of siRNA improves silencing activity and nuclease resistance. Further, we found that the modified siRNA suppressed HCV replication more efficiently than unmodified siRNA. Thus, the naphthalene biaryl modification may hold promise as a method for improvement of the silencing activity and nuclease-resistance of siRNAs.
|